Product nameAnti-TP53INP2 antibody
See all TP53INP2 primary antibodies
DescriptionRabbit polyclonal to TP53INP2
Tested applicationsSuitable for: IHC-P, WB, ICC/IFmore details
Species reactivityReacts with: Mouse, Rat, Human
Synthetic peptide corresponding to Human TP53INP2 conjugated to keyhole limpet haemocyanin. Within the center region.
Database link: Q8IXH6
- WB: HeLa, RAW264.7, H9C2 cell lysate. IHC: Human breast cancer tissue. ICC/IF: HeLa cells.
Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C. Avoid freeze / thaw cycle.
Storage bufferpH: 7.3
Preservative: 0.01% Sodium azide
Constituents: 0.42% Potassium phosphate, 0.87% Sodium chloride, 30% Glycerol
Concentration information loading...
Our Abpromise guarantee covers the use of ab273012 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|IHC-P||1/50 - 1/200.|
|WB||1/500 - 1/2000. Predicted molecular weight: 24 kDa.|
|ICC/IF||1/50 - 1/100.|
- Information by UniProt
- C20orf110 antibody
- Diabetes and obesity regulated; p53 inducible protein U antibody
- DOR antibody
All lanes : Anti-TP53INP2 antibody (ab273012) at 1/500 dilution
Lane 1 : HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate
Lane 2 : RAW 264.7 (mouse macrophage cell line transformed with Abelson murine leukemia virus) whole cell lysate
Lane 3 : H9c2 (rat heart myoblast cell line) whole cell lysate
Predicted band size: 24 kDa
Formalin-fixed, parafin-embedded human breast cancer tissue stained for TP53INP2 using ab273012 at 1/50 dilution in immunohistochemical analysis.
Immnunofluorescence analysis of HeLa (human epithelial cell line from cervix adenocarcinoma) cells labeling TP53INP2 (red) using ab273012 at 1/50 dilution.
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
ab273012 has not yet been referenced specifically in any publications.